scispace - formally typeset
R

Ruth Pidsley

Researcher at Garvan Institute of Medical Research

Publications -  38
Citations -  5907

Ruth Pidsley is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: DNA methylation & Epigenetics. The author has an hindex of 24, co-authored 37 publications receiving 4899 citations. Previous affiliations of Ruth Pidsley include King's College London & St. Vincent's Health System.

Papers
More filters
Journal ArticleDOI

A data-driven approach to preprocessing Illumina 450K methylation array data

TL;DR: It is demonstrated that quantile normalization methods produce marked improvement, even in highly consistent data, by all three metrics, and that careful selection of preprocessing steps can minimize variance and thus improve statistical power, especially for the detection of the small absolute DNA methylation changes likely associated with complex disease phenotypes.
Journal ArticleDOI

Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling

TL;DR: The EPIC array is a significant improvement over the HM450 array, with increased genome coverage of regulatory regions and high reproducibility and reliability, providing a valuable tool for high-throughput human methylome analyses from diverse clinical samples.
Journal ArticleDOI

Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood

TL;DR: This study reinforces the importance of DNA methylation in regulating cellular phenotype across tissues, and highlights genomic patterns of epigenetic variation across functionally distinct regions of the brain, providing a resource for the epigenetics and neuroscience research communities.
Journal ArticleDOI

De novo identification of differentially methylated regions in the human genome

TL;DR: The agglomeration of genomically localised individual methylation sites into discrete DMRs is currently best served by a combination of DM-signal smoothing and subsequent threshold specification, and the design of the 450K array shows preference for CpG sites that are more likely to be differentially methylated, but its overall coverage does not adequately reflect the depth and complexity of methylation signatures afforded by sequencing.